Cargando…
The impact of the coronavirus disease 2019 (covid-19) on male sexual health
OBJECTIVES: During the Coronavirus Disease 2019 (COVID-19) pandemic, there was an increase in the amount of men seeking treatment at urology outpatient clinics for sexual complaints. However, it is unknown whether this condition is directly related to COVID-19. The impact of COVID-19 on male sexual...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679756/ http://dx.doi.org/10.1016/j.jsxm.2022.08.092 |
_version_ | 1784834267594883072 |
---|---|
author | Gultekin, Mehmet H. Yildirim, Omer Akkus, Emre Ozkara, Prof. Hamdi |
author_facet | Gultekin, Mehmet H. Yildirim, Omer Akkus, Emre Ozkara, Prof. Hamdi |
author_sort | Gultekin, Mehmet H. |
collection | PubMed |
description | OBJECTIVES: During the Coronavirus Disease 2019 (COVID-19) pandemic, there was an increase in the amount of men seeking treatment at urology outpatient clinics for sexual complaints. However, it is unknown whether this condition is directly related to COVID-19. The impact of COVID-19 on male sexual health was explored in the present study. METHODS: Individuals in the male sexual health cohort of our clinic were retrospectively examined. Men who applied to our clinic in the last 6 months and had a history of COVID-19 afterward were invited for an assesment at the 3rd month post COVID-19. Follicle-stimulating hormone (FSH), luteinizing hormone (LH), total testosterone (TT), and prolactin (PRL) levels were all measured. Furthermore, the Premature ejaculation diagnostic tool (PEDT), the Chronic prostatitis symptom index (NIH-CPSI), the International Index of erectile function-5 (IIEF-5), the Beck depression inventory (BDI), and the Beck anxiety inventory (BAI) scores were recorded. The pre-covid and post-covid data of the subjects were compared. RESULTS: The mean age of the participants was 34.8±7.7, the mean body mass index was 26.82±5.3, and the mean modified Charlson comorbidity index was 0.2±0.41. COVID-19 severity was mild in 19/25 (76%) and moderate in 6/25 (24%) of the subjects. LH, FSH, TT, and PRL levels did not differ between precovid and postcovid periods (p>0.05). There was no significant change in PEDT, NIH-CPSI, IIEF-5, or BAI scale scores in the postcovid period (p>0.05), although there was an remarkable decrease in BDI scores as compared to the precovid period (p>0.05). CONCLUSIONS: While there was no difference in sex hormone levels or scale scores used to assess premature ejaculation, erectile dysfunction, chronic prostatitis, or anxiety, we noticed an unanticipated decrease in depression levels in individuals recovering from COVID-19. More precise results on the impact of COVID-19 on male sexual health could be revealed in future cohort studies with higher case numbers. CONFLICTS OF INTEREST: The authors declare no conflict of interest. |
format | Online Article Text |
id | pubmed-9679756 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96797562022-11-22 The impact of the coronavirus disease 2019 (covid-19) on male sexual health Gultekin, Mehmet H. Yildirim, Omer Akkus, Emre Ozkara, Prof. Hamdi J Sex Med I-07 OBJECTIVES: During the Coronavirus Disease 2019 (COVID-19) pandemic, there was an increase in the amount of men seeking treatment at urology outpatient clinics for sexual complaints. However, it is unknown whether this condition is directly related to COVID-19. The impact of COVID-19 on male sexual health was explored in the present study. METHODS: Individuals in the male sexual health cohort of our clinic were retrospectively examined. Men who applied to our clinic in the last 6 months and had a history of COVID-19 afterward were invited for an assesment at the 3rd month post COVID-19. Follicle-stimulating hormone (FSH), luteinizing hormone (LH), total testosterone (TT), and prolactin (PRL) levels were all measured. Furthermore, the Premature ejaculation diagnostic tool (PEDT), the Chronic prostatitis symptom index (NIH-CPSI), the International Index of erectile function-5 (IIEF-5), the Beck depression inventory (BDI), and the Beck anxiety inventory (BAI) scores were recorded. The pre-covid and post-covid data of the subjects were compared. RESULTS: The mean age of the participants was 34.8±7.7, the mean body mass index was 26.82±5.3, and the mean modified Charlson comorbidity index was 0.2±0.41. COVID-19 severity was mild in 19/25 (76%) and moderate in 6/25 (24%) of the subjects. LH, FSH, TT, and PRL levels did not differ between precovid and postcovid periods (p>0.05). There was no significant change in PEDT, NIH-CPSI, IIEF-5, or BAI scale scores in the postcovid period (p>0.05), although there was an remarkable decrease in BDI scores as compared to the precovid period (p>0.05). CONCLUSIONS: While there was no difference in sex hormone levels or scale scores used to assess premature ejaculation, erectile dysfunction, chronic prostatitis, or anxiety, we noticed an unanticipated decrease in depression levels in individuals recovering from COVID-19. More precise results on the impact of COVID-19 on male sexual health could be revealed in future cohort studies with higher case numbers. CONFLICTS OF INTEREST: The authors declare no conflict of interest. Published by Elsevier Inc. 2022-11 2022-11-22 /pmc/articles/PMC9679756/ http://dx.doi.org/10.1016/j.jsxm.2022.08.092 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | I-07 Gultekin, Mehmet H. Yildirim, Omer Akkus, Emre Ozkara, Prof. Hamdi The impact of the coronavirus disease 2019 (covid-19) on male sexual health |
title | The impact of the coronavirus disease 2019 (covid-19) on male sexual health |
title_full | The impact of the coronavirus disease 2019 (covid-19) on male sexual health |
title_fullStr | The impact of the coronavirus disease 2019 (covid-19) on male sexual health |
title_full_unstemmed | The impact of the coronavirus disease 2019 (covid-19) on male sexual health |
title_short | The impact of the coronavirus disease 2019 (covid-19) on male sexual health |
title_sort | impact of the coronavirus disease 2019 (covid-19) on male sexual health |
topic | I-07 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679756/ http://dx.doi.org/10.1016/j.jsxm.2022.08.092 |
work_keys_str_mv | AT gultekinmehmeth theimpactofthecoronavirusdisease2019covid19onmalesexualhealth AT yildirimomer theimpactofthecoronavirusdisease2019covid19onmalesexualhealth AT akkusemre theimpactofthecoronavirusdisease2019covid19onmalesexualhealth AT ozkaraprofhamdi theimpactofthecoronavirusdisease2019covid19onmalesexualhealth AT gultekinmehmeth impactofthecoronavirusdisease2019covid19onmalesexualhealth AT yildirimomer impactofthecoronavirusdisease2019covid19onmalesexualhealth AT akkusemre impactofthecoronavirusdisease2019covid19onmalesexualhealth AT ozkaraprofhamdi impactofthecoronavirusdisease2019covid19onmalesexualhealth |